Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


VANCOUVER, British Columbia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences:


Posted: 2024-11-21 11:05:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Zymeworks Announces Participation in Upcoming Investor Conferences - Newscast

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Tue, 05 Nov 2024 03:00:00 GMT For information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on X. This press release includes “forward-looking statements” or information within the meaning of the ...

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Mon, 04 Nov 2024 15:59:00 GMT For information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on X. This press release includes “forward-looking statements” or information within the meaning ...

Zymeworks Announces Participation in Upcoming Investor Conferences

Mon, 28 Oct 2024 23:00:00 GMT VANCOUVER, British Columbia, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Zymeworks Announces Participation in Upcoming Investor Conferences

Mon, 28 Oct 2024 20:00:00 GMT We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zymeworks Announces Participation in Upcoming Investor Conferences

Mon, 28 Oct 2024 17:00:00 GMT VANCOUVER, British Columbia, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...


Blow Us A Whistle